28410686|t|Relations between doses cumulated in bone marrow and dose delivery techniques during radiation therapy of cervical and endometrial cancer
28410686|a|To compare normal tissue complication probability (NTCP) and average doses in the bone marrow (BM), obtained for five different radiotherapy delivery and planning strategies of cervical and endometrial cancer. 50 patients were taken to analysis. For each case, 3 different dose delivery techniques were used: 4-field, X15MV, 3DCRT; 7-field, X6MV, IMRT; and 2-arc, X6MV, VMAT. Two optimization scenarios were used for the IMRT and VMAT plans generation: with (+) and without (-) the inclusion of the BM as an optimized structure. Average doses and dose-volume histogram parameters for the PTV, BM, bladder, rectum, bowels and femoral heads were compared. In addition, the BM doses were analyzed with respect to the PTV and/or volume of the BM, and NTCP for the BM were computed. The dose in PTV for evaluated plans was similar. The worst doses in organs at risk were obtained for 3DCRT. Using the BM during the optimization of IMRT and VMAT reduces an average dose in BM without increasing the doses in the bladder, rectum and bowels. Differences between doses in BM for IMRT(+) and VMAT(+) plans were similar while NTCP was lower for VMAT(+). A correlation between average dose in BM and the volume ratio of BM and PTV was found for each technique. Using the BM during the optimization of the IMRT and VMAT plans effectively reduces the dose in BM without increasing the dose in the bladder, rectum and bowels. The VMAT(+) plans were characterized by the lowest NTCP.
28410686	0	9	Relations	T080	C0439849
28410686	18	33	doses cumulated	T077	C2986497
28410686	37	48	bone marrow	T024	C0005953
28410686	53	57	dose	T081	C0178602
28410686	58	77	delivery techniques	T169	C1705822
28410686	85	102	radiation therapy	T061	C1522449
28410686	106	114	cervical	T191	C0007847
28410686	119	137	endometrial cancer	T191	C0007103
28410686	141	148	compare	T052	C1707455
28410686	149	187	normal tissue complication probability	T081	C0033204
28410686	189	193	NTCP	T081	C0033204
28410686	199	212	average doses	T081	C0392762
28410686	220	231	bone marrow	T024	C0005953
28410686	233	235	BM	T024	C0005953
28410686	256	265	different	T080	C1705242
28410686	266	287	radiotherapy delivery	T081	C0034620
28410686	292	311	planning strategies	T170	C0032076
28410686	315	323	cervical	T191	C0007847
28410686	328	346	endometrial cancer	T191	C0007103
28410686	351	359	patients	T101	C0030705
28410686	374	382	analysis	T062	C0936012
28410686	411	415	dose	T081	C0178602
28410686	416	435	delivery techniques	T169	C1705822
28410686	447	468	4-field, X15MV, 3DCRT	T061	C0600521
28410686	470	489	7-field, X6MV, IMRT	T061	C1512814
28410686	495	512	2-arc, X6MV, VMAT	T061	C3641892
28410686	518	530	optimization	T052	C2698650
28410686	531	540	scenarios	T169	C0683579
28410686	559	563	IMRT	T061	C1512814
28410686	568	572	VMAT	T061	C3641892
28410686	573	578	plans	T170	C0599880
28410686	591	595	with	T033	C0243095
28410686	604	611	without	T080	C0332288
28410686	620	629	inclusion	T080	C1512693
28410686	637	639	BM	T024	C0005953
28410686	646	655	optimized	T052	C2698650
28410686	656	665	structure	T082	C0678594
28410686	667	674	Average	T081	C1510992
28410686	675	680	doses	T081	C0178602
28410686	685	706	dose-volume histogram	T170	C3827011
28410686	707	717	parameters	T033	C0449381
28410686	726	729	PTV	T081	C0454199
28410686	731	733	BM	T024	C0005953
28410686	735	742	bladder	T023	C0005682
28410686	744	750	rectum	T023	C0034896
28410686	752	758	bowels	T023	C0021853
28410686	763	776	femoral heads	T023	C0015813
28410686	782	790	compared	T052	C1707455
28410686	809	811	BM	T024	C0005953
28410686	812	817	doses	T081	C0178602
28410686	823	831	analyzed	T062	C0936012
28410686	852	855	PTV	T081	C0454199
28410686	863	869	volume	T081	C0449468
28410686	877	879	BM	T024	C0005953
28410686	885	889	NTCP	T081	C0033204
28410686	898	900	BM	T024	C0005953
28410686	906	914	computed	T059	C1441526
28410686	920	924	dose	T081	C0178602
28410686	928	931	PTV	T081	C0454199
28410686	936	951	evaluated plans	T170	C0599880
28410686	956	963	similar	T080	C2348205
28410686	975	980	doses	T081	C0178602
28410686	984	998	organs at risk	T029	C2936599
28410686	1017	1022	3DCRT	T061	C0600521
28410686	1034	1036	BM	T024	C0005953
28410686	1048	1060	optimization	T052	C2698650
28410686	1064	1068	IMRT	T061	C1512814
28410686	1073	1077	VMAT	T061	C3641892
28410686	1078	1085	reduces	T080	C0392756
28410686	1089	1096	average	T081	C1510992
28410686	1097	1101	dose	T081	C0178602
28410686	1105	1107	BM	T024	C0005953
28410686	1108	1115	without	T080	C0332288
28410686	1116	1126	increasing	T081	C0205217
28410686	1131	1136	doses	T081	C0178602
28410686	1144	1151	bladder	T023	C0005682
28410686	1153	1159	rectum	T023	C0034896
28410686	1164	1170	bowels	T023	C0021853
28410686	1172	1183	Differences	T080	C1705242
28410686	1192	1197	doses	T081	C0178602
28410686	1201	1203	BM	T024	C0005953
28410686	1208	1215	IMRT(+)	T061	C1512814
28410686	1220	1227	VMAT(+)	T061	C3641892
28410686	1228	1233	plans	T170	C0599880
28410686	1239	1246	similar	T080	C2348205
28410686	1253	1257	NTCP	T081	C0033204
28410686	1272	1279	VMAT(+)	T061	C3641892
28410686	1283	1294	correlation	T080	C1707520
28410686	1303	1310	average	T081	C1510992
28410686	1311	1315	dose	T081	C0178602
28410686	1319	1321	BM	T024	C0005953
28410686	1330	1342	volume ratio	T081	C1547056
28410686	1346	1348	BM	T024	C0005953
28410686	1353	1356	PTV	T081	C0454199
28410686	1376	1385	technique	T169	C0449851
28410686	1397	1399	BM	T024	C0005953
28410686	1411	1423	optimization	T052	C2698650
28410686	1431	1435	IMRT	T061	C1512814
28410686	1440	1444	VMAT	T061	C3641892
28410686	1445	1450	plans	T170	C0599880
28410686	1463	1470	reduces	T080	C0392756
28410686	1475	1479	dose	T081	C0178602
28410686	1483	1485	BM	T024	C0005953
28410686	1486	1493	without	T080	C0332288
28410686	1494	1504	increasing	T081	C0205217
28410686	1509	1513	dose	T081	C0178602
28410686	1521	1528	bladder	T023	C0005682
28410686	1530	1536	rectum	T023	C0034896
28410686	1541	1547	bowels	T023	C0021853
28410686	1553	1560	VMAT(+)	T061	C3641892
28410686	1561	1566	plans	T170	C0599880
28410686	1572	1585	characterized	T052	C1880022
28410686	1593	1599	lowest	T080	C1708760
28410686	1600	1604	NTCP	T081	C0033204